GOGOA & SCIENCE
In order to demonstrate the clinical efficacy and safety of medical devices, Gogoa proactively conducts clinical trials and studies. Below you can see the pre-post-marketing studies conducted with Gogoa's medical devices in major centres and reference hospitals.
Exoskeleton‑based training improves
walking independence in incomplete spinal
cord injury patients: results from a randomized
Clinical trial published in the Journal of NeuroEngineering and Rehabilitation detailing the results of a rehabilitation trial with HANK, an ambulatory robotic exoskeleton for lower limbs. The trial was conducted in paraplegic patients with spinal cord injury (SCI) less than 1 year after injury at the Hospital Nacional de Parapléjicos de Toledo.
Robot therapy with the H2 exoskeleton for gait rehabilitation in patients with incomplete spinal cord injry. A clinical experience
Clinical trial conducted with the HANK precursor exoskeleton (H2). The performance of the Exo H2 exoskeleton was consistent during a clinical gait rehabilitation protocol. It was shown to be a safe therapy with no unwanted effects and good patient tolerance. These results justify clinical trials with an adequate sample size.
Physiological evaluation of different control modes of lower limb robotic exoskeleton H2 in patients with incomplete spinal cord injury
This article has a strong physiotherapeutic slant, as the main author is a specialist physiotherapist. It deals with the effects of physical exercise on people with spinal cord injuries, using the H2 element as an approach.
Integration of brain-computer interface and rehabilitation-oriented lower limb exoskeleton
This article could be considered slightly more generic, as it presents a brain-computer interface (BCI) designed to control an exoskeleton. Through task-focused attention, this system enables relatively free movement. However, the more one is distracted from the walking task, the less freedom is granted by the controller, providing an incentive to refocus on the walking task.
The H2 robotic exoskeleton for gait rehabilitation after stroke: early findings from a clinical study
Clinical trial conducted with the HANK precursor exoskeleton (H2) at TIRR Memorial (Houston, Texas) with stroke patients. The objective was to evaluate the safety and usability of the medical device.
A flexible architecture to enhance wearable robots: Integration of EMG-informed models
The integration of the H2 exoskeleton with a neuromuscular model is detailed, with the purpose of operating in tandem. A thorough estimation of the torque generated using a complex arrangement of EMG electrodes is carried out and applied to the exoskeleton.
Monitoring of gait stability with exoskeletons based on proprioceptive information
This is an intriguing reference, as by using the exoskeleton, a simulation of a fall is carried out, allowing the algorithm to predict such an event and thus take preventive measures regarding the use of the exoskeleton in case of a fall.